BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24913706)

  • 21. The Role of Abnormal Methylation of Wnt5a Gene Promoter Regions in Human Epithelial Ovarian Cancer: A Clinical and Experimental Study.
    Jin P; Song Y; Yu G
    Anal Cell Pathol (Amst); 2018; 2018():6567081. PubMed ID: 30079293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.
    Zhu J; Zhang S; Gu L; Di W
    Carcinogenesis; 2012 Dec; 33(12):2334-43. PubMed ID: 22964660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single CpG island methylation is not sufficient to maintain the silenced expression of CASPASE-8 apoptosis-related gene among women with epithelial ovarian cancer.
    Braga Lda C; Silva LM; Ramos AP; Piedade JB; Vidigal PV; Traiman P; da Silva Filho AL
    Biomed Pharmacother; 2014 Feb; 68(1):87-91. PubMed ID: 24412083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis.
    Vuillemenot BR; Pulling LC; Palmisano WA; Hutt JA; Belinsky SA
    Carcinogenesis; 2004 Apr; 25(4):623-9. PubMed ID: 14656941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.
    Sernbo S; Gustavsson E; Brennan DJ; Gallagher WM; Rexhepaj E; Rydnert F; Jirström K; Borrebaeck CA; Ek S
    BMC Cancer; 2011 Sep; 11():405. PubMed ID: 21943380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
    Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
    J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic and expression analysis of TRAIL-R2 and BCL2: on the TRAIL to knowledge of apoptosis in ovarian tumors.
    Braga Lda C; Silva LM; Piedade JB; Traiman P; da Silva Filho AL
    Arch Gynecol Obstet; 2014 May; 289(5):1061-9. PubMed ID: 24190693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.
    Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Significance of Retinoic Acid Receptor Beta Promoter Methylation in Prostate Cancer: A Meta-Analysis.
    Dou M; Zhou X; Fan Z; Ding X; Li L; Wang S; Xue W; Wang H; Suo Z; Deng X
    Cell Physiol Biochem; 2018; 45(6):2497-2505. PubMed ID: 29554659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between RAR-beta gene expression defect and its methylation].
    Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer.
    Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF
    Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation status of nine tumor suppressor genes in multiple myeloma.
    Braggio E; Maiolino A; Gouveia ME; Magalhães R; Souto Filho JT; Garnica M; Nucci M; Renault IZ
    Int J Hematol; 2010 Jan; 91(1):87-96. PubMed ID: 20037750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
    Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
    Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FBXW12, a novel F box protein-encoding gene, is deleted or methylated in some cases of epithelial ovarian cancer.
    De La Chesnaye E; Méndez JP; López-Romero R; De Los Angeles Romero-Tlalolini M; Vergara MD; Salcedo M; Ojeda SR
    Int J Clin Exp Pathol; 2015; 8(9):10192-203. PubMed ID: 26617728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer.
    Vo LT; Thuan TB; Thu DM; Uyen NQ; Ha NT; To TV
    Asian Pac J Cancer Prev; 2013; 14(12):7713-8. PubMed ID: 24460357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer.
    Ivanova T; Petrenko A; Gritsko T; Vinokourova S; Eshilev E; Kobzeva V; Kisseljov F; Kisseljova N
    BMC Cancer; 2002 Mar; 2():4. PubMed ID: 11945179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Methylation of selected tumor-supressor genes in benign and malignant ovarian tumors].
    Cul'bová M; Lasabová Z; Stanclová A; Tilandyová P; Zúbor P; Fiolka R; Danko J; Visnovský J
    Ceska Gynekol; 2011 Sep; 76(4):274-9. PubMed ID: 22026068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.
    Juhlin CC; Kiss NB; Villablanca A; Haglund F; Nordenström J; Höög A; Larsson C
    PLoS One; 2010 Mar; 5(3):e9472. PubMed ID: 20208994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.